These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Implications of upstream glycoprotein IIb/IIIa inhibition and coronary artery stenting in the invasive management of unstable angina/non-ST-elevation myocardial infarction: a comparison of the Thrombolysis In Myocardial Infarction (TIMI) IIIB trial and the Treat angina with Aggrastat and determine Cost of Therapy with Invasive or Conservative Strategy (TACTICS)-TIMI 18 trial. Sabatine MS; Morrow DA; Giugliano RP; Murphy SA; Demopoulos LA; DiBattiste PM; Weintraub WS; McCabe CH; Antman EM; Cannon CP; Braunwald E Circulation; 2004 Feb; 109(7):874-80. PubMed ID: 14757697 [TBL] [Abstract][Full Text] [Related]
6. Glycoprotein IIb/IIIa inhibitors in patients with unstable angina/non-ST-segment elevation myocardial infarction: appropriate interpretation of the guidelines. Antman EM Am Heart J; 2003 Oct; 146(4 Suppl):S18-22. PubMed ID: 14564302 [TBL] [Abstract][Full Text] [Related]
7. A cold start for oral glycoprotein IIb/IIIa antagonists. Curtin R; Fitzgerald DJ Eur Heart J; 2000 Dec; 21(24):1992-4. PubMed ID: 11102247 [No Abstract] [Full Text] [Related]
8. Platelet glycoprotein inhibitors in patients with medically managed acute coronary syndrome: does the enthusiasm exceed the science? Schriger DL; Herbert ME Ann Emerg Med; 2001 Sep; 38(3):249-55. PubMed ID: 11524643 [TBL] [Abstract][Full Text] [Related]
9. The use of glycoprotein IIb/IIIa receptor inhibitors in unstable angina. Ageno W; Turpie AG G Ital Cardiol; 1999 Nov; 29(11):1357-65. PubMed ID: 10609142 [No Abstract] [Full Text] [Related]
10. Platelet glycoprotein IIb/IIIa inhibitor therapy in non-ST segment elevation acute coronary syndromes. Elmouchi DA; Bates ER Minerva Cardioangiol; 2003 Oct; 51(5):547-60. PubMed ID: 14551523 [TBL] [Abstract][Full Text] [Related]
11. The evolving role of glycoprotein IIb/IIIa inhibitor therapy in contemporary care of acute coronary syndrome patients. Tricoci P; Peterson ED J Interv Cardiol; 2006 Oct; 19(5):449-55. PubMed ID: 17020570 [TBL] [Abstract][Full Text] [Related]
12. [Glycoprotein IIB/IIIA receptor blockers as treatment of acute coronary syndromes and interventional cardiology]. Abramovitch N; Halon DA; Flugelman Y; Lewis BS Harefuah; 1998 Jul; 135(1-2):41-7. PubMed ID: 10909532 [No Abstract] [Full Text] [Related]
13. Results of IIb/IIIa receptor blockade in patients with unstable angina. Vahanian A; Michaud P; Garbarz E Semin Interv Cardiol; 1999 Jun; 4(2):61-6. PubMed ID: 10473874 [TBL] [Abstract][Full Text] [Related]
14. Contemporary view of the acute coronary syndromes. Moustapha A; Anderson HV J Invasive Cardiol; 2003 Feb; 15(2):71-9. PubMed ID: 12556619 [No Abstract] [Full Text] [Related]
18. Glycoprotein IIb/IIIa inhibitors and acute coronary syndromes: summary report of the full submission to NICE, and beyond. Manoharan G; Adgey AA Heart; 2001 Sep; 86(3):259-61. PubMed ID: 11514474 [No Abstract] [Full Text] [Related]
19. Antiplatelet therapy in interventional cardiology: II. Glycoprotein IIb/IIIa inhibitors. Jafary FH; Kimmelstiel CD J Thromb Thrombolysis; 2000 Feb; 9(2):163-74. PubMed ID: 10613998 [No Abstract] [Full Text] [Related]